Caricamento...
In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy
We report the selection of Clostridium difficile resistant to the rifamycin class of antibiotics in a patient within 32 h of receiving rifaximin for the treatment of recurrent C. difficile diarrhea. Resistance was associated with single nucleotide substitutions within rpoB.
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3486587/ https://ncbi.nlm.nih.gov/pubmed/22908175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00974-12 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|